• Publications
  • Influence
Prognostic Factors in Pediatric Cancer Patients Admitted to the Pediatric Intensive Care Unit
Higher mortality and morbidity are well established in children with malignancies in whom intensive care admissions are required. A retrospective cohort study was conducted to assess the risk factorsExpand
  • 41
  • 4
Childhood Acute Lymphoblastic Leukemia in Turkey: Factors Influencing Treatment and Outcome: A Single Center Experience
There is limited data about the long-term treatment outcome and prognosis of childhood acute lymphoblastic leukemia (ALL) in developing countries. Our study was designed to assess survival data andExpand
  • 30
  • 3
The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2.
Genetic disorders of lymphocyte cytotoxicity predispose patients to hemophagocytic lymphohistiocytosis (HLH). Reduced lymphocyte cytotoxicity has been demonstrated in Hermansky-Pudlak syndrome type 2Expand
  • 54
  • 2
  • Open Access
Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: A randomized and open‐label study
This is a prospective, randomized, and open‐label clinical trial that examines the efficiency and safety of PIP/TAZO monotherapy in comparison to cefepime (CEF), for the empirical treatment ofExpand
  • 33
  • 2
Quality of Life Assessment in Hematopoietic Stem Cell Transplantation Performed on Thalassemia Major Patients
Although successful hematopoietic stem cell transplantation (HSCT) can offer a cure in thalassemia major, there are only a few and noncomprehensive studies of its effect on the quality of life (QoL),Expand
  • 13
  • 2
POSTTRANSPLANT ORAL IRON-CHELATING THERAPY IN PATIENTS WITH β-THALASSEMIA MAJOR
Allogeneic hematopoetic stem cell transplantation (HSCT) is the only radical cure of β-thalassemia. However, iron overload remains a cause of morbidity and mortality in posttransplant period. TheExpand
  • 8
  • 1
Outcome of autologous hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory Hodgkin's lymphoma
This study evaluates the outcome of 66 pediatric patients with rrHL who underwent autoHSCT. Twenty‐nine patients experienced early relapse, and 19 patients experienced late relapse. Of 18 newlyExpand
  • 5
  • 1
Safety and Outcomes of Extracorporeal Photopheresis With the Therakos Cellex System for Graft-Versus-Host Disease in Pediatric Patients
Extracorporeal photopheresis (ECP) is a difficult procedure to perform in the pediatric population. This is a retrospective review of 12 pediatric patients who underwent photopheresis with theExpand
  • 12
Better Posttransplant Outcome With Fludarabine Based Conditioning in Multitransfused Fanconi Anemia Patients Who Underwent Peripheral Blood Stem Cell Transplantation
Several investigators have been looking for less toxic conditioning regimen for stem cell transplantation in Fanconi anemia (FA) patients because of sensitivity to DNA cross-linking agents andExpand
  • 7
The value of donor lymphocyte infusions in thalassemia patients at imminent risk of graft rejection following stem cell transplantation
The aim was to evaluate the feasibility of donor lymphocyte infusion (DLI) in transplanted patients with thalassemia who were at imminent risk of graft rejection (GR).
  • 8